Variables | Guideline disease category | |
Bipolar disorder | Major depressive disorder | |
Number of all authors, n | 33 | 42 |
Role of guideline authors, n (%) | ||
Writing authors* | 4 (12.1) | 14 (33.3) |
Supporting authors† | 5 (15.2) | 12 (28.6) |
Guideline development committee authors‡ | 24 (72.7) | 16 (38.1) |
Payments by author roles | ||
Total payment amounts, US$ | ||
Writing authors* | 532 717 | 1 659 595 |
Supporting authors† | 12 140 | 930 986 |
Guideline development committee authors‡ | 2 548 718 | 1 448 508 |
Number of authors receiving payments by author roles, n (%) | ||
Writing authors* | 4 (100) | 14 (100) |
Supporting authors† | 4 (80.0) | 10 (83.3) |
Guideline development committee authors‡ | 22 (91.7) | 16 (100) |
Median payment amounts per author, US$ | ||
Writing authors* | 135 867 (78 553–187 806) | 87 610 (16 945–111 567) |
Supporting authors† | 1788 (715–1845) | 60 120 (1573–142 732) |
Guideline development committee authors‡ | 34 569 (11 588–184 068) | 34 569 (14 331–149 624) |
*Writing authors directly contributed to the creation of guidelines.
†Supporting authors could have contributed to identifying relevant evidence and performing literature reviews.
‡Guideline development committee authors were not directly involved in the creation of the guidelines, but critically reviewed the contents and recommendations of the initial guideline draft and revised them if necessary.